Results 51 to 60 of about 3,715,425 (177)

Pharmacotherapies in Parkinson Disease: Investigating Trends and Adverse Health Outcomes

open access: yes, 2016
Parkinson disease (PD) is the second most common neurodegenerative disease worldwide, with estimates suggesting that PD prevalence and incidence will increase with aging populations.
Crispo, James Alexander George
core   +2 more sources

A CASE STUDY ON SCHIZOPHRENIA INDUCED MULTIPLE COMORBIDITIES

open access: yes, 2018
Schizophrenia is a mental disorder characterized by abnormal social behavior which includes false beliefs, confusion, and auditory hallucination. Antipsychotic drugs therapy increases the risk of developing diabetes mellitus and coronary artery disease ...
Justin Jacob Abraham   +5 more
core   +1 more source

Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation

open access: yes, 2006
The maleic and fumaric diamides preparation of (O,O-diacetyl)-L-Dopa-methylester [(+)-4, (+)-5] are reported; they were synthesized in order to attenuate marked fluctuations of L-DOPA (LD) plasma levels and to overcome the problem of low bioavailability ...
SOZIO, Piera   +5 more
core   +2 more sources

Hospitalization due to drug poisoning in under-five-year-old children in Minas Gerais/Brazil, 2009 – 2018

open access: yes, 2020
Objetivo: descrever as internações hospitalares no estado de Minas Gerais devido às intoxicações medicamentosas, em crianças menores de cinco anos de idade, entre os anos de 2009 e 2018.
Pereira, Mariana Linhares   +2 more
core   +1 more source

Quantum Chemical Analysis of Potential Anti-Parkinson Agents [PDF]

open access: yes
Monoamine oxidases (MAOs) are amine oxidoreductase falvoenzymes that belong to the integral proteins of the outer mitochondrial membrane. MAO exists in two distinct isoforms; MAO-A and MAO-B.
اعظم, باقری   +3 more
core  

Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence

open access: yes, 2016
The use of medication with anticholinergic properties is widespread among older subjects. Many drugs of common use such as antispasmodics, bronchodilators, antiarrhythmics, antihistamines, anti-hypertensive drugs, antiparkinson agents, skeletal muscle ...
Landi, Francesco   +14 more
core   +1 more source

SINTESIS BERBAGAI KOMPOSIT LOGAM NANOPARTIKEL MENGGUNAKAN EKSTRAK BIJI KARABENGUK (Mucuna pruriens) DAN AKTIVITASNYA SEBAGAI ANTIPARKINSON [PDF]

open access: yes, 2020
Biji karabenguk (Mucuna pruriens) telah digunakan dalam pengobatan penyakit Parkinson karena memiliki kandungan L-dopa. Senyawa L-dopa merupakan obat standar Penyakit Parkinson.
Dhia Azmi Azzahra, -
core  

L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents

open access: yes, 2007
not ...
A. IANNITELLI   +8 more
core  

Table_1_Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence.XLSX

open access: yes, 2019
Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons, appearance of Lewy bodies and presence of neuroinflammation.
Elisa Storelli (390139)   +4 more
core   +1 more source

5-methyl-8-N-substituted-thiocarbamoyl-7,8-diazabicyclo[4.3.0] non-6-enes: Evaluation as BSAO inhibitors and pharmacological activity screening

open access: yes, 1996
WOS: A1996WG66200003PubMed ID: 9050209In this study a series of 5-methyl-8-N-substituted-thiocarbamoyl-7,8-diazabicyclo[4.3.0] non-6-enes derivatives previously synthesized and separated to their stereoisomers, were evaluated as BSAO inhibitors and ...
Yeşilada, A   +4 more
core  

Home - About - Disclaimer - Privacy